CoreValve’s 18-French ReValving? System For Percutaneous Aortic Valve Replacement (PAVR) Demonstrated ‘Live’ At TCT 2007
CoreValve announced that its third-generation, proprietary aortic heart valve was implanted successfully - non-surgically - in a ‘high-risk’ patient suffering from Chronic Obstructive Pulmonary Disease (COPD) using CoreValve’s percutaneous, 18-French ReValving? System, at the ‘TCT 2007′ (Transcatheter Cardiovascular Therapeutics) scientific symposium in Washington, D.C. [click link for full article]
More: continued here
Filed under: Cardiovascular on October 25th, 2007